查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1676238

全球處方皮膚病治療市場研究報告 - 產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global Prescription Dermatology Therapeutics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 157 Pages | 商品交期: 最快1-2個工作天內

價格

全球處方皮膚病治療市場規模預計將從 2024 年的 519.6 億美元成長到 2033 年的 1149.2 億美元，在 2026 年至 2033 年的預測期內呈現 9.22% 的強勁年複合成長率(CAGR)。

受皮膚病發病率不斷上升和對有效治療方案的需求不斷成長的推動，處方皮膚病治療市場有望實現大幅成長。隨著牛皮癬、濕疹、痤瘡和皮膚癌等疾病變得越來越常見，醫療保健提供者正在尋求創新的皮膚病療法來應對這些挑戰。市場正在見證生物製劑和標靶療法發展的激增，與傳統治療方法相比，這些療法具有更高的功效和安全性。這些進步對於慢性皮膚病的治療尤其重要，因為慢性皮膚病通常需要長期治療。

此外，對個人化醫療的日益重視正在影響處方皮膚病治療市場。隨著醫療保健提供者越來越認知到根據個別患者需求量身定做治療的重要性，考慮遺傳和環境因素的治療的需求正在上升。這一趨勢正在推動研究和開發工作，旨在尋找可以指導治療決策和改善患者預後的特定生物標記。此外，遠距皮膚病學和行動醫療應用等數位健康技術的整合，正在增強人們獲得皮膚病護理的機會，並促進對治療效果的遠端監控。

此外，皮膚健康意識運動和倡導的興起也促進了處方皮膚病治療市場的成長。隨著消費者對皮膚狀況和可用的治療方案的了解越來越多，他們更有可能尋求醫療建議並尋求有效的治療方法。製藥公司、醫療保健提供者和患者權益團體之間的合作正在促進創新並擴大皮膚病治療的機會。總之，處方皮膚病治療市場將實現強勁成長，其特點是技術進步、注重個性化護理以及致力於改善皮膚病患者的生活品質。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

目錄

第 1 章：前言

  • 報告描述
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究流程
    • 市場研究方法

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：處方皮膚病治療產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 市場吸引力分析：按產品類型
    • 按配銷通路進行市場吸引力分析
    • 市場吸引力分析：按地區

第4章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球處方皮膚病治療市場分析：依產品類型

  • 概覽：依產品類型
  • 歷史與預測資料分析：按產品類型
  • 痤瘡和紅斑痤瘡藥物
  • 牛皮癬藥物
  • 皮膚炎和脂漏性皮膚炎藥物
  • 真菌感染藥物
  • 皮膚癌藥物
  • 其他

第 6 章：全球處方皮膚病治療市場分析：按分銷管道

  • 按配銷通路概覽
  • 按配銷通路進行的歷史和預測資料分析
  • 醫院藥房
  • 零售藥局
  • 郵購藥局

第 7 章：全球處方皮膚病治療市場分析：按地區分類

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美各細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲各細分市場銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東和非洲分部銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第 8 章：處方皮膚病治療公司的競爭格局

  • 處方皮膚病治療市場競爭
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品發布
  • 其他進展

第9章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • AbbVie Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Janssen Biotech Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Novartis AG
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Amgen Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Celgene Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Pfizer Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • LEO Pharma A/S
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Eli Lilly And Company
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bausch Health Companies Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Sun Pharmaceuticals Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Aclaris Therapeutics Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Aurobindo Pharma Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

Product Code: VMR11211184

Global Prescription Dermatology Therapeutics Market size is anticipated to grow from USD 51.96 Billion in 2024 to USD 114.92 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 9.22% during the forecast period of 2026 to 2033.

The prescription dermatology therapeutics market is poised for significant growth, driven by the increasing prevalence of skin disorders and the rising demand for effective treatment options. As conditions such as psoriasis, eczema, acne, and skin cancer become more common, healthcare providers are seeking innovative dermatological therapies to address these challenges. The market is witnessing a surge in the development of biologics and targeted therapies that offer improved efficacy and safety profiles compared to traditional treatments. These advancements are particularly relevant in the management of chronic skin conditions, where long-term treatment is often necessary.

Moreover, the growing emphasis on personalized medicine is influencing the prescription dermatology therapeutics market. As healthcare providers increasingly recognize the importance of tailoring treatments to individual patient needs, the demand for therapies that consider genetic and environmental factors is rising. This trend is driving research and development efforts aimed at identifying specific biomarkers that can guide treatment decisions and improve patient outcomes. Additionally, the integration of digital health technologies, such as teledermatology and mobile health applications, is enhancing access to dermatological care and facilitating remote monitoring of treatment efficacy.

Furthermore, the rise of awareness campaigns and advocacy for skin health is contributing to the growth of the prescription dermatology therapeutics market. As consumers become more informed about skin conditions and available treatment options, they are more likely to seek medical advice and pursue effective therapies. The collaboration between pharmaceutical companies, healthcare providers, and patient advocacy groups is fostering innovation and expanding access to dermatological treatments. In summary, the prescription dermatology therapeutics market is set for robust growth, characterized by technological advancements, a focus on personalized care, and a commitment to improving the quality of life for individuals with skin disorders.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

  • Acne & Rosacea Drugs
  • Psoriasis Drugs
  • Dermatitis & Seborrhea Drugs
  • Fungal Infection Drugs
  • Skin Cancer Drugs
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmac+J388
  • COMPANIES PROFILED
  • AbbVie Inc.
  • Janssen Biotech Inc.
  • Novartis AG
  • Amgen Inc.
  • Celgene Corporation
  • Pfizer Inc.
  • LEO Pharma A/S
  • Eli Lilly and Company
  • Bausch Health Companies Inc.
  • Sun Pharmaceuticals Ltd.
  • Aclaris Therapeutics Inc.
  • Aurobindo Pharma Ltd.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PRESCRIPTION DERMATOLOGY THERAPEUTICS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Distribution Channel
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PRESCRIPTION DERMATOLOGY THERAPEUTICS MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Acne & Rosacea Drugs Historic and Forecast Sales By Regions
  • 5.4. Psoriasis Drugs Historic and Forecast Sales By Regions
  • 5.5. Dermatitis & Seborrhea Drugs Historic and Forecast Sales By Regions
  • 5.6. Fungal Infection Drugs Historic and Forecast Sales By Regions
  • 5.7. Skin Cancer Drugs Historic and Forecast Sales By Regions
  • 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL PRESCRIPTION DERMATOLOGY THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 6.1. Overview By Distribution Channel
  • 6.2. Historical and Forecast Data Analysis By Distribution Channel
  • 6.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 6.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 6.5. Mail Order Pharmacies Historic and Forecast Sales By Regions

7. GLOBAL PRESCRIPTION DERMATOLOGY THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE PRESCRIPTION DERMATOLOGY THERAPEUTICS COMPANIES

  • 8.1. Prescription Dermatology Therapeutics Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF PRESCRIPTION DERMATOLOGY THERAPEUTICS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. AbbVie Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Janssen Biotech Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Novartis AG
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Amgen Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Celgene Corporation
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Pfizer Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. LEO Pharma A/S
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Eli Lilly And Company
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Bausch Health Companies Inc.
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Sun Pharmaceuticals Ltd.
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. Aclaris Therapeutics Inc.
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Aurobindo Pharma Ltd
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Acne & Rosacea Drugs Market Sales By Geography (USD MN)
  • Psoriasis Drugs Market Sales By Geography (USD MN)
  • Dermatitis & Seborrhea Drugs Market Sales By Geography (USD MN)
  • Fungal Infection Drugs Market Sales By Geography (USD MN)
  • Skin Cancer Drugs Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Mail Order Pharmacies Market Sales By Geography (USD MN)
  • Global Prescription Dermatology Therapeutics Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Prescription Dermatology Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Prescription Dermatology Therapeutics Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Acne & Rosacea Drugs Market Sales By Geography (USD MN)
  • Psoriasis Drugs Market Sales By Geography (USD MN)
  • Dermatitis & Seborrhea Drugs Market Sales By Geography (USD MN)
  • Fungal Infection Drugs Market Sales By Geography (USD MN)
  • Skin Cancer Drugs Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Mail Order Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.